Uncategorized

FDA CBER Director Dr. Peter Marks Discusses Industry Growth, Collaboration and Communication

At the DIA Global 2024 Conference, Dr. Peter Marks, director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration (FDA), and Lori Ellis, head of insights at BioSpace, discussed the advancements being made to help drive forward drug and medical device development. Not surprisingly, Dr. Marks stressed the need

FDA CBER Director Dr. Peter Marks Discusses Industry Growth, Collaboration and Communication Read More »

Scroll to Top